Search

Displaying results 9211 - 9220 of 9617 in total
  1. Drug

    Stamulumab

    go.drugbank.com/drugs/DB05915
    Investigational

    MYO-029 is a human anti-GDF-8 monoclonal antibody, which is being developed to treat muscle-wasting diseases including muscular dystrophy and age-related sarcopenia.

  2. Drug

    Elvucitabine

    go.drugbank.com/drugs/DB06236
    Investigational

  3. Drug

    Declopramide

    go.drugbank.com/drugs/DB06421
    Experimental

  4. Drug

    ISIS 113715

    go.drugbank.com/drugs/DB05506
    Investigational

    ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measure...

  5. Drug

    Galiximab

    go.drugbank.com/drugs/DB04901
    Investigational

    Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive drug.

  6. Drug

    Citatuzumab Bogatox

    go.drugbank.com/drugs/DB06072
    Investigational

    VB6-845 has demonstrated effective cancer cell killing properties in pre-clinical tests.

  7. Drug

    Urefibrate

    go.drugbank.com/drugs/DB20849
    Experimental

    Urefibrate has a monoisotopic molecular weight of 354.02 Da.

  8. Drug

    Ebaresdax

    go.drugbank.com/drugs/DB21496
    Investigational

    Ebaresdax has a monoisotopic molecular weight of 266.07 Da.

  9. Drug

    Picafibrate

    go.drugbank.com/drugs/DB19574
    Experimental

    Picafibrate has a monoisotopic molecular weight of 362.1 Da.

  10. Drug

    Tiafibrate

    go.drugbank.com/drugs/DB19874
    Experimental

    Tiafibrate has a monoisotopic molecular weight of 686.23 Da.